#BEGIN_DRUGCARD DB04459

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C9H4Cl2O2

# Chemical_IUPAC_Name:
3,4-dichloro-1H-isochromen-1-one

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
3,4-Dichloroisocoumarin

# HET_ID:
DIC

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C9H4Cl2O2/c10-7-5-3-1-2-4-6(5)9(12)13-8(7)11/h1-4H

# InChI_Key:
InChIKey=SUGXUUGGLDCZKB-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4459

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
215.033

# Molecular_Weight_Mono:
213.958834786

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1DIC

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
3.14

# Predicted_LogS:
-3.5

# Predicted_Water_Solubility:
6.97e-02 g/l

# Primary_Accession_No:
DB04459

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
1609

# PubChem_Substance_ID:
46507031

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01202

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
ClC1=C(Cl)C2=CC=CC=C2C(=O)O1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:21 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
CFD

# Drug_Target_1_GenBank_ID_Gene:
M84526

# Drug_Target_1_GenBank_ID_Protein:
178626

# Drug_Target_1_GeneCard_ID:
CFD

# Drug_Target_1_Gene_Name:
CFD

# Drug_Target_1_Gene_Sequence:
>687 bp
ATGCTGGGCGGCAGAGAGGCCGAGGCGCACGCGCGGCCCTACATGGCGTCGGTGCAGCTG
AACGGCGCGCACCTGTGCGCAGGCGTCCTGGTGGCGGAGCGGTGGGTGCTGAGCGCGGCG
CACTGCCTGGAGGACGCGGCCGACGGGAAGGTGCAGGTTCTCCTGGGCGCGCACTCCCTG
TCGCAGCCGGAGCCCTCCAAGCGCCTGTACGACGTGCTCCGCGCAGTGCCCCACCCGGAC
AGCCAGCCCGACACCATCGACCACGACCTCCTGCTGCTACAGCTGTCGGAGAAGGCCACA
CTGGGCCCTGCTGTGCGCCCCCTGCCCTGGCAGCGCGTGGACCGCGACGTGGCACCGGGA
ACTCTCTGCGACGTGGCCGGCTGGGGCATAGTCAACCACGCGGGCCGCCGCCCGGACAGC
CTGCAGCACGTGCTCTTGCCAGTGCTGGACCGCGCCACCTGCAACCGGCGCACGCACCAC
GACGGCGCCATCACCGAGCGCTTGATGTGCGCGGAGAGCAATCGCCGGGACAGCTGCAAG
GGTGACTCCGGGGGCCCGCTGGTGTGCGGGGGCGTGCTCGAGGGCGTGGTCACCTCGGGC
TCGCGCGTTTGCGGCAACCGCAAGAAGCCCGGGATCTACACCCGCGTGGCGAGCTATGCG
GCCTGGATCGACAGCGTCCTGGCCTAG

# Drug_Target_1_General_Function:
Involved in protease activity

# Drug_Target_1_General_References:
1374388	White RT, Damm D, Hancock N, Rosen BS, Lowell BB, Usher P, Flier JS, Spiegelman BM: Human adipsin is identical to complement factor D and is expressed at high levels in adipose tissue. J Biol Chem. 1992 May 5;267(13):9210-3.
6363133	Johnson DM, Gagnon J, Reid KB: Amino acid sequence of human factor D of the complement system. Similarity in sequence between factor D and proteases of non-plasma origin. FEBS Lett. 1984 Jan 30;166(2):347-51.
6383466	Niemann MA, Bhown AS, Bennett JC, Volanakis JE: Amino acid sequence of human D of the alternative complement pathway. Biochemistry. 1984 May 22;23(11):2482-6.
6776531	Davis AE 3rd: Active site amino acid sequence of human factor D. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4938-42.
6821372	Johnson DM, Gagnon J, Reid KB: Factor D of the alternative pathway of human complement. Purification, alignment and N-terminal amino acid sequences of the major cyanogen bromide fragments, and localization of the serine residue at the active site. Biochem J. 1980 Jun 1;187(3):863-74.
6987665	Volanakis JE, Bhown A, Bennett JC, Mole JE: Partial amino acid sequence of human factor D:homology with serine proteases. Proc Natl Acad Sci U S A. 1980 Feb;77(2):1116-9.
7592653	Kim S, Narayana SV, Volanakis JE: Crystal structure of a complement factor D mutant expressing enhanced catalytic activity. J Biol Chem. 1995 Oct 13;270(41):24399-405.
8289289	Narayana SV, Carson M, el-Kabbani O, Kilpatrick JM, Moore D, Chen X, Bugg CE, Volanakis JE, DeLucas LJ: Structure of human factor D. A complement system protein at 2.0 A resolution. J Mol Biol. 1994 Jan 14;235(2):695-708.

# Drug_Target_1_HGNC_ID:
HGNC:2771

# Drug_Target_1_HPRD_ID:
00600

# Drug_Target_1_ID:
3346

# Drug_Target_1_Locus:
19p13.3

# Drug_Target_1_Molecular_Weight:
27004

# Drug_Target_1_Name:
Complement factor D

# Drug_Target_1_Number_of_Residues:
253

# Drug_Target_1_PDB_ID:
1FDP

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00089	Trypsin

# Drug_Target_1_Protein_Sequence:
>Complement factor D precursor
MHSSVYFAVLVLLGAAACAARPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQW
VLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQL
SEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCN
RRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTR
VASYAAWIDSVLA

# Drug_Target_1_Reaction:
Selective cleavage of Arg!Lys bond in complement factor B when in complex with complement subcomponent C3b or with cobra venom factor

# Drug_Target_1_Signals:
1-20

# Drug_Target_1_Specific_Function:
Factor D cleaves factor B when the latter is complexed with factor C3b, activating the C3bbb complex, which then becomes the C3 convertase of the alternate pathway. Its function is homologous to that of C1s in the classical pathway

# Drug_Target_1_SwissProt_ID:
P00746

# Drug_Target_1_SwissProt_Name:
CFAD_HUMAN

# Drug_Target_1_Synonyms:
Adipsin
C3 convertase activator
Complement factor D precursor
EC 3.4.21.46
Properdin factor D

# Drug_Target_1_Theoretical_pI:
7.99

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB04459
